SGN19A

Biological Seattle Genetics, Inc.
Total Payments
$2.1M
Transactions
354
Doctors
7
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $2.1M 354 7

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $2.1M 316 99.1%
Honoraria $15,000 6 0.7%
Travel and Lodging $2,320 8 0.1%
Consulting Fee $1,250 1 0.1%
Food and Beverage $811.32 23 0.0%

Payments by Type

Research
$2.1M
316 transactions
General
$19,381
38 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
SG019A0003 Seattle Genetics, Inc. $1.1M 0
SG019A0004 Seattle Genetics, Inc. $764,721 0
SG019A0002 Seattle Genetics, Inc. $124,906 0
SG019A0001 Seattle Genetics, Inc. $74,427 0

Top Doctors Receiving Payments for SGN19A

Doctor Specialty Location Total Records
Unknown — New York, NY $2.1M 316
, MD Medical Oncology New York, NY $4,415 11
, DO, MS Hematology Boston, MA $3,233 8
, MD Hematology & Oncology Salt Lake City, UT $2,646 5
, MD Medical Oncology Saint Louis, MO $2,646 5
, M.D Ophthalmology Houston, TX $2,596 4
, M.D Hematology & Oncology Springfield, OR $2,596 4
, MD Gastroenterology Durham, NC $1,250 1

Manufacturing Companies

Product Information

  • Type Biological
  • Total Payments $2.1M
  • Total Doctors 7
  • Transactions 354

About SGN19A

SGN19A is a biological associated with $2.1M in payments to 7 healthcare providers, recorded across 354 transactions in the CMS Open Payments database. The primary manufacturer is Seattle Genetics, Inc..

Payment data is available from 2017 to 2017. In 2017, $2.1M was paid across 354 transactions to 7 doctors.

The most common payment nature for SGN19A is "Unspecified" ($2.1M, 99.1% of total).

SGN19A is associated with 4 research studies, including "SG019A0003" ($1.1M).